Scientists from The Institute of Advanced Studies at Princeton and the University of California discovered that the underlying process in tumor formation is the same as for life itself—evolution.
After analyzing a half million gene mutations, the researchers found that although different gene mutations control different cancer pathways, each pathway was controlled by only one set of gene mutations. This suggests that a molecular "survival of the fittest" scenario plays out in every living creature as gene mutations strive for ultimate survival through cancerous tumors.
This finding, which appears in the August 2008 issue of The FASEB Journal (http://www.fasebj.org), improves our understanding of how evolution shapes life in all forms, while laying a foundation for new cancer drugs and treatments.
"This study lays the groundwork for understanding the nature of different mutations in cancers," said Chen-Hsiang Yeung, first author of the study, "and helps with understanding the mechanisms of cancers and their responses to drug treatments."
To arrive at these conclusions, researchers analyzed about 500,000 cancer mutation records from the Catalog of Somatic Mutations in Cancer database and then divided the data into 45 tissue types. Within each tissue type, they calculated the frequency that multiple genes were mutated in the same sample. They identified the frequencies of mutations that were significantly higher or lower than if the genes had mutated independently. Then they mapped out how these genes ultimately lead to cancerous tumors and checked whether the genes occurring in specific tissues used the same or different cancer pathways.
"Little could Darwin have known that his 'Origin of the Species' would one day explain the 'Origin of the Tumor,'" said Gerald Weissmann, MD, Editor-in-Chief of The FASEB Journal. "This research report completely changes our understanding of the many gene mutations that cause cancer."
Cody Mooneyhan | EurekAlert!
One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie
The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy